FriedJA, RamasubbuK, BhattR, TopkaraVK, ClerkinKJ, HornE, RabbaniL, BrodieD, JainSS, KirtaneA, MasoumiA, TakedaK, KumaraiahD, BurkhoffD, LeonM, SchwartzA, UrielN, and SayerG. (2020). The variety of cardiovascular presentations of COVID-19. Circulation [Epub ahead of print]; DOI: 10.1161/CIRCULATIONAHA.120.047164.
2.
GattinoniL, ChiumelloD, CaironiP, BusanaM, RomittiF, BrazziL, and CamporotaL. (2020). COVID-19 pneumonia: different respiratory treatments for different phenotypes?. Intensive Care Med [Epub ahead of print]; DOI: 10.1007/s00134-020-06033-2.
3.
KuboK, HanaokaM, HayanoT, MiyaharaT, HachiyaT, HayasakaM, KoizumiT, FujimotoK, KobayashiT, and HondaT. (1998). Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema. Respir Physiol, 111:301–310.
4.
LitchJA. (1999). Endotracheal intubation and mechanical ventilation following respiratory arrest from high altitude pulmonary edema. West J Med, 170:174–176.
5.
LuksAM, FreerL, GrissomCK, McIntoshSE, SchoeneRB, SwensonER, and HackettPH. (2020). COVID-19 lung injury is not high altitude pulmonary edema. High Alt Med Biol, 21:192–193.
6.
MaggioriniM, MélotC, PierreS, PfeifferF, GreveI, SartoriC, LeporiM, HauserM, ScherrerU, and NaeijeR. (2001). High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation, 103:2078–2083.
7.
MasonRJ. (2020). Pathogenesis of COVID-19 from a cell biology perspective. Eur Resp J [Epub ahead of print]; DOI: 10.1183/13993003.00607-2020.
SolaimanzadehI. (2020). Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). Cureus, 12:e7343.
10.
StreamJO, LuksAM, and GrissomCK. (2009). Lung disease at high altitude. Expert Rev Respir Med, 3:635–650.
11.
SwensonER and BärtschP. (2012). High-altitude pulmonary edema. Compr Physiol, 2:2753–2773.
12.
SwensonER, MaggioriniM, MongovinS, GibbsJS, GreveI, MairbäurlH, and BärtschP. (2002). Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA, 287:2228–2235.
13.
TangN, BaiH, ChenX, GongJ, LiD, and SunZ. (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost [Epub ahead of print]; DOI: 10.1111/jth.14817.